Back

Uncontrolled cardiometabolic risk factors and risk of cardiac dysfunction in psoriasis: the PSOCADIA study

31 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment Cardiovascular Risk Assessment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Cecillie Jansen

Hellerup (Denmark)

5 More presentations in this session

Presentation thumbnail
Distribution and temporal trends of predicted ten-year and lifetime atherosclerotic cardiovascular disease risk in Chinese adults, 2013-2023: national cross-sectional surveys
Assistant Professor C. Li (Beijing, CN)
Abstract
Presentation thumbnail
Relationship between cumulative exposure to systemic inflammation response index and risk of all-cause mortality in middle-aged and older adults with cardiovascular-kidney-metabolic syndrome stage 0–2
Professor R. Huang (Beijing, CN)
Abstract
Presentation thumbnail
The association of multi-system health status and its longitudinal changes with cardiovascular disease risk: insights from multinational cohorts study
Miss Y. Xin (Beijing, CN)
Abstract
Presentation thumbnail
Associations between a body shape index and cardiometabolic risk markers: age- and sex-specific patterns in a Brazilian population
Doctor T. Minari (Sao Paulo, BR)
Abstract
Presentation thumbnail
Cardiovascular risk factor control after implementation of mandatory risk assessment in a tertiary cardiovascular centre
Miss A. Palikuca (Novi Sad, RS)
Abstract

Access the full session

Session thumbnail
Cardiovascular risk assessment

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Subclinical cardiac organ damage in patients with moderate to severe psoriasis treated with infliximab
27 August 2021
thumbnail
Congress Presentation
Uncontrolled diabetes predicts anxiety and depression in CAD patients
27 August 2021
thumbnail
Congress Presentation
Relationships between metabolic syndrome and outcomes in dilated cardiomyopathy.
22 May 2023
thumbnail
Congress Presentation
Blood pressure and LDL-cholesterol control in patients with primary hypertension is far from optimal: results from a large observational, multicentric, prospective study
1 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources